Table 3 Description of sub-cohorts with eGFR above and below 60 ml/min/1.73 m 2
From: Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
N = 2838 | eGFR ≥60 ml/min/1.73 m2 | eGFR <60 ml/min/1.73 m2 |
|---|---|---|
N = 2075 | N = 763 | |
FGF23 Range (pg/ml) | 1.5 - 800 | 3.5 - 800 |
FGF23 median (IQR)(pg/ml) | 40.3 (30–52) | 54.1 (40–70) |
Age (years) | 75.1 ± 3.2 | 76.4 ± 2.9 |
BMI (kg/m 2 ) | 26.2 ± 3.5 | 27.0 ± 3.7 |
Smoking (%) | 138 (7%) | 96 (12%) |
Diabetes (%) | 174 (8%) | 90 (12%) |
Hypertension (%) | 661 (32%) | 360 (47%) |
Prevalent MI | 12% | 20% |
Prevalent stroke | 5% | 9% |
eGFR (ml/min/1.73 m 2 ) | 78 (70–89) | 50 (43–55) |
PTH median IQR (pmol/L) | 4.1 (2.8 - 5.5) | 4.9 (3.4 - 6.9) |
Pi (mmol/L) | 1.07 ± 0.16 | 1.09 ± 0.18 |
Ca (mmol/L) | 2.36 ± 0.15 | 2.36 ± 0.17 |
Albumin (g/L) | 43.3 ± 3.3 | 42.8 ± 4.2 |
25OHvitD (nmol/L) | 69.9 ± 23 | 69.7 ± 24 |
Mortality rate/1000 py (95%CI) | 219/9458.4 py | 134/3309.1 |
23.2 (20.1 - 26.3) | 40.5 (33.7 - 47.3) | |
Cardiovascular deaths/1000 py (95%CI) | 73/9458.4 py | 59/3309.1 |
7.7 (5.9 - 9.5) | 17.8 (13.3 - 22.3) |